Michael Kramer

Michael Kramer

Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.

  1. Stocks

    JNJ & PFE are Leading Healthcare Higher (JNJ, PFE)

    A positive article on Johnson & Johnson and a Pfizer dividend increase are boosting their shares, and the group higher.
  2. Stocks

    PFE Bounces, But Is It Just A Dead Cat? (PFE, XLV)

    Pfizer, along with Akili Interactive, reported positive data that could help with the detection of onset Alzheimer's disease.
  3. Stocks

    Lions Gate Closes on Starz Acquisition (LGF.A, LGF.B)

    Lionsgate and Starz announced the completion of their $4.4 billion merger yesterday.
  4. Stocks

    Allergan Jumps In Early Trading (AGN)

    Shares of AGN are surging by 4% following comments out of Citi and Credit Suisse.
  5. Stocks

    Broadcom Poised for Higher Highs (AVGO)

    The semiconductor solutions company reported strong results after the close yesterday. Analysts are following up with upgrades. ...
  6. Stocks

    AVGO Beats On Top & Bottom Line, Shares Up (AVGO)

    Broadcom beats analyst expectations for Q4 top and bottom line.
  7. Stocks

    Allergan Talks Strategy at Citi Conference (AGN)

    Brent Saunders, AGN's CEO had much to say about drug pricing and acquisition possibilities.
  8. Stocks

    Teva Gets Boost On CEO's Positive Comments (TEVA)

    Teva shares are up by about 3% following comments from the CEO at the Citi Global Healthcare Conference.
  9. Stocks

    PFE Lower After Record Fine From The UK (PFE)

    The company was fined for its unfair practices and pricing.
  10. Stocks

    Is Pandora Looking For Another Suitor? (P, SIRI)

    Pandora is moving higher on reports from CNBC that the company is looking outside of Sirius.
  11. Stocks

    Allergan Down on Negative Analyst Comments (AGN)

    Piper Jaffray issued a Negative report on AGN this morning noting the business is not likely to see a rebound.
  12. Stocks

    LGF Shares Surge Higher For a Second Day (LGF)

    Shares of LGF are surging more than 3% today, as options activity picks up again.
  13. Stocks

    Broadcom Getting a Boost Ahead of Earnings (AVGO)

    Pacific Crest is bullish on Broadcom ahead its Thursday earnings release.
  14. Stocks

    Analysts Weigh in on Sirius/Pandora (SIRI, P)

    Shares of Pandora are receiving a boost this morning after RBC and OPCO both saw the potential for Sirius and Pandora to ...
  15. Stocks

    Allergan Viewed Positively At JP Morgan (AGN)

    This morning AGN's rating and price target were reiterated at JP Morgan, which sees the stock a compelling opportunity.